A Phase 1 Study of RO7623066 Alone and in Combination in Patients With Advanced Solid Tumors

NCT05240898 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

116

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: RO7623066
DRUG: Olaparib
DRUG: Carboplatin

Sponsor

Hoffmann-La Roche